Market research
2DR.F Inspire Medical Systems, Inc
F EUR Healthcare
Latest close
As of 29 Oct 2026
Test a moving-average rule with historical data.
Market facts
- Market cap
- 2B
- P/E ratio
- 15.94
- Analyst target
- 257.9
- Dividend yield
- Not available
- Beta
- 0.73
Profile
Instrument facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- Not available
- Market cap
- 2B
- P/E ratio
- 15.94
- Analyst target
- 257.9
- Dividend yield
- Not available
- Beta
- 0.73
About
About Inspire Medical Systems, Inc
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Research context
Inspire Medical Systems, Inc appears in PyInvesting’s Frankfurt Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the 2DR.F discussion.
5 years, 7 months ago
Inspire Medical Systems, Inc is currently in a long term downtrend where the price is trading 7.5% below its 200 day moving average.
From a valuation standpoint, the stock is 96.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 48.0.
Inspire Medical Systems, Inc's total revenue rose by 71.0% to $46M since the same quarter in the previous year.
Its net income has increased by 17.6% to $-7M since the same quarter in the previous year.
Finally, its free cash flow grew by 27.7% to $-5M since the same quarter in the previous year.
Based on the above factors, Inspire Medical Systems, Inc gets an overall score of 4/5.